Academic Detailing
The IEHP Pharmacy Academic Detailing team is an educational and evidence-based outreach program for our providers and pharmacies. We perform phone and one-on-one outreaches with physicians, nurse practitioners, physician assistants, and pharmacy staff. Our goal is to transform the prescriber and pharmacy practice and enhance the provider, pharmacist and member experience.
Clinical Drug Education
Clinical Drug Education provides materials that focus on a specific drug, drug class, and/or disease state. These materials contain pharmacological and clinical practice information to assist providers and pharmacies in their practice. As new drug information is available, it is important to stay up to date on clinical research findings to assist with member care and medication-use decisions.
Clinical Drug Education
A growing trend in healthcare is the use of biosimilar drugs. The following information will assist you and your practice on prescribing biosimilars.
Biosimilars
Electronic Prescribing (e-Rx)
Electronic prescribing is a growing standard in the healthcare industry. Most electronic health record systems offer electronic prescription capabilities. The information below will provide insight to the practice of e-prescribing.
Formulary Utilization
The IEHP Formulary offers a variety of drugs based on safety and efficacy for any condition. The information below will help you find out how to access and interpret the formulary
- Medi-Cal FAQ (PDF)
- Medicare FAQ (PDF)
- Formulary Criteria Guide (PDF)
The process of submitting a prior authorization may be cumbersome for your practice. The information below will help you understand this process and assist with receiving a proper decision in a timely manner.
UPA Submission
For any questions regarding Pharmacy Academic Detailing Training please contact:
PharmacyAcademicDetailing@iehp.org
IEHP DualChoice Cal MediConnect Plan (Medicare-Medicaid Plan)
What is IEHP DualChoice Cal MediConnect Plan (Medicare-Medicaid Plan)?
IEHP DualChoice is a Cal MediConnect Plan. A Cal MediConnect Plan is an organization made up of doctors, hospitals, pharmacies, providers of long-term services and supports, behavioral health providers, and other providers. It also has care coordinators and care teams to help you manage all your providers and services. They all work together to provide the care you need.
What is the goal of this program?
The goal is to improve care by integrating the following healthcare services:
- Medicare and Medi-Cal benefits
- Long-term care
- Behavioral health
- Home and community-based services (HCBS) such as Community-Based Adult Services (CBAS) and Multipurpose Senior Services Program (MSSP).
Who is eligible for IEHP DualChoice?
People who have both Medicare and Medi-Cal. For a complete list of who is included or excluded, visit Who Qualifies?
Plans and Benefits
IEHP DualChoice integrates healthcare services to better coordinate care and improve health.
How to Enroll
To enroll, please call:
- IEHP DualChoice Medicare Team at 1-800-741-IEHP (4347), 8am-8pm (PST), 7 days a week, including holidays. TTY/TDD users should call 1-800-718-4347, OR
- Health Care Options (HCO) at 1-844-580-7272, 8am – 5pm (PST), Monday – Friday. TTY/TDD users should call 1-800-430-7077.
For more information, visit the DHCS website. By clicking on this link, you will be leaving the IEHP DualChoice website. You may also call IEHP DualChoice for help at 1-877-273-IEHP (4347), 8am – 8pm (PST), 7 days a week, including holidays. TTY/TDD users should call 1-800-718-4347 (4347).
- Plan Benefits and Cost-Sharing: Find out about plan benefits which are the types of medical care that are covered. Also view information on cost-sharing which is how much you will pay for services or prescription drugs, including monthly plan premium and co-payment.
- Part D Prescription Drugs: Get information on pharmacy benefits, IEHP network pharmacies, out-of-network coverage, pharmacy transition process, drug utilization management, prescription mail order, and medication therapy management.
- Provider Access Information: Learn about network providers, primary care providers, specialists and how to choose a provider in our network. Read about our quality assurance activities and find out what happens if your doctor leaves our plan.
- Grievances, Coverage Determination and Appeals Process: Find out what to do if you have a problem or complaint about your medical care or Part D.
- Helpful Information: View your rights and responsibilities upon disenrollment and as a Member of IEHP. You will also find important forms for 2018 such as our Privacy Notice, Plan Transition Process and the section of CMS' website regarding Best Available Evidence.
- Service Area: Find out which zip codes in Riverside and San Bernardino counties are included in our service area.
IEHP DualChoice Cal MediConnect Plan (Medicare-Medicaid Plan) is a Health Plan that contracts with both Medicare and Medi-Cal to provide benefits of both programs to enrollees.
Information on this page is current as of October 15, 2018.
H5355_CMC_19_1059755 Accepted
Clinical Information
In this section find these resources that include printable reference documents for your convenience and ease of use:
- Clinical Practice Guidelines
- Diabetes DME Coverage
- Disease Therapy Management Program
- High Risk Medications
- Medication Therapy Management
- Pharmacy Pain Management
- Prior Authorization Drug Treatment Criteria
- Safety Resources
Maximum Allowable Charges (MAC)
On this site, you will find information on IEHP Maximum Allowable Charges (MAC) and the IEHP MAC list. IEHP Maximum Allowable Charges are applied to generically approved drug products with therapeutic equivalent evaluations rated by the FDA or similar nationally recognized pricing reference. Please note that the IEHP MAC does not apply to any IEHP Medicare line of business. IEHP Medicare line of business currently utilizes the ARGUS National Network MAC (please refer to your contractual agreements with ARGUS for any disputes in pricing).
Since pharmacy acquisition costs are considered proprietary information, and there is no MAC reference that is considered to be the “gold standard” for reimbursement purposes, IEHP has contracted with GlassBox Analytics’ Predictive Acquisition Cost (PAC) program to generate a custom MAC list. The IEHP MAC list is developed based on the acquisition cost analysis provided using Predictive Acquisition Cost (PAC) Model and is fully transparent.
The PAC model applies a unique predictive analytic model and takes into account of industry MAC benchmarks, published price lists, existing pricing benchmarks, behavioral metrics, supply/demand measures, and survey-based acquisition costs. This model allows IEHP to create a more accurate pricing model for generic drugs utilizing recent pricing changes.
MAC Review Process:
To comply with Assembly Bill No. 627, or the amendments to California Business and Professions Code, Division 2, Chapter 9.5 Audits of Pharmacy Benefits, Sections 4430, 4432, and 4440, IEHP is updating its current MAC policy with an effective date of January 1, 2016.
IEHP understands the importance of the accuracy and timeliness of Maximum Allowable Charges (MAC) update process, and based on the above regulation, has increased the frequency of the IEHP MAC drug price review from once every one month to once every seven days.
A drug is included on IEHP MAC list if:
- The drug is listed as “A” or “B” rated in the most recent version of the federal Food and Drug Administration’s approved drug products with therapeutic equivalent evaluations, also known as the Orange Book, or has an “NA,” “NR,” or “Z” rating or a similar rating by a nationally recognized pricing reference, such as Medi-Span or First DataBank.
- The drug is generally available for purchase in the state from a national or regional wholesaler.
- The drug is not obsolete.
Types of Appeals:
Appealing the disposition of MAC or Non-MAC Drug: If a contracting pharmacy believes a drug does not meet the requirements for a MAC drug, the pharmacy may appeal the drug and must submit evidence to support why the drug does not meet MAC drug requirements.
Appealing an existing MAC Price: A contracting pharmacy may appeal the MAC price for a drug on the IEHP MAC list if the MAC price of the drug is below the cost at which is the drug is available for purchase or acquisition cost. Pharmacy providers must submit wholesale invoice to support the case.
Time-Frame for Appeals:
Pharmacies are allowed to appeal for a drug MAC no more than 14 days following receipt of payment for the claim.
IEHP will make a final determination within seven business days of the receipt of appeal.
If request is denied, IEHP will provide the reason of denial and the NDC of an equivalent drug that may be purchased at equal or less than the MAC.
If request is upheld, MAC for the drug will be updated within one calendar day of the date of determination. The appealing pharmacy may reverse and resubmit the claim upon which the appeal was based to receive the correct payment.
Required Documents:
IEHP MAC dispute form
For appeals regarding the disposition of MAC or Non-MAC Drug: Evidence the drug does not meet MAC drug requirements
For appeals regarding an existing MAC Price: Proof of acquisition cost at NDC level (i.e. wholesale invoice)
IEHP Review Process:
IEHP will review the MAC appeal request with the pricing information provided by our third party vendor which includes pricing information from various wholesalers. A request will be denied if the purchase cost of the drug is within the range of available purchase costs based on available market information. IEHP understands there will be variation of price based on different wholesalers and makes every effort to reimburse price fairly and competitively. However, we are not in a position to provide recommendations regarding a pharmacy’s procurement practices and will review price based on market information.
How to Appeal:
Pharmacy Providers must submit a MAC Dispute Resolution Request Form (PDF) - Effective 1/1/2016 AND required information to IEHP (via fax at 909-891-1577 or via email to MAC@iehp.org).
By implementing the procedure detailed above, IEHP anticipates that the most significant pricing changes will be acted upon timely. It is our goal to streamline this process and react to pricing changes proactively, and we are confident that pharmacy providers will get a fair reimbursement based on the current MAC structure.
If you have any questions, please feel free to contact the IEHP Pharmaceutical Services Department at 909-890-2049.
You will need Adobe Acrobat Reader 6.0 or later to view the PDF files. Click here to download a free copy by clicking Adobe Acrobat Reader. By clicking on this link, you will be leaving the IEHP website.
IEHP Maximum Allowable Charges (MAC) List:
Last Upload 09/19/2019 (PDF)
Effective 09/12/2019 - 09/18/2019 (PDF)
Effective 09/05/2019 - 09/11/2019 (PDF)
Effective 08/29/2019 - 09/04/2019 (PDF)
Effective 08/22/2019 - 08/28/2019 (PDF)
Effective 08/15/2019 - 08/21/2019 (PDF)
Effective 08/08/2019 - 08/14/2019 (PDF)
Effective 08/01/2019 - 08/07/2019 (PDF)
Effective 07/25/2019 - 07/31/2019 (PDF)
Effective 07/18/2019 - 07/24/2019 (PDF)
Effective 07/11/2019 - 07/17/2019 (PDF)
Effective 07/04/2019 - 07/10/2019 (PDF)
Effective 06/27/2019 - 07/03/2019 (PDF)
Effective 06/20/2019 - 06/26/2019 (PDF)
Effective 06/13/2019 - 06/19/2019 (PDF)
Effective 06/06/2019 - 06/12/2019 (PDF)
Effective 05/30/2019 - 06/05/2019 (PDF)
Effective 05/23/2019 - 05/29/2019 (PDF)
Effective 05/16/2019 - 05/22/2019 (PDF)
Effective 05/09/2019 - 05/15/2019 (PDF)
Effective 05/01/2019 - 05/08/2019 (PDF)
Effective 04/25/2019 - 04/30/2019 (PDF)
Effective 04/18/2019 - 04/24/2019 (PDF)
Effective 04/11/2019 - 04/17/2019 (PDF)
Effective 04/04/2019 - 04/10/2019 (PDF)
Effective 03/28/2019 - 04/03/2019 (PDF)
Effective 03/21/2019 - 03/27/2019 (PDF)
Effective 03/14/2019 - 03/20/2019 (PDF)
Effective 03/07/2019 - 03/13/2019 (PDF)
Effective 02/28/2019 - 03/06/2019 (PDF)
Effective 02/21/2019 - 02/27/2019 (PDF)
Effective 02/14/2019 - 02/20/2019 (PDF)
Effective 02/07/2019 - 02/13/2019 (PDF)
Effective 01/31/2019 - 02/06/2019 (PDF)
Effective 01/24/2019 - 01/30/2019 (PDF)
Effective 01/17/2019 - 01/23/2019 (PDF)
Effective 01/10/2019 - 01/16/2019 (PDF)
Effective 01/03/2019 - 01/09/2019 (PDF)
Effective 12/27/2018 - 01/02/2019 (PDF)
Effective 12/20/2018 - 12/26/2018 (PDF)
Effective 12/13/2018 - 12/19/2018 (PDF)
Effective 12/06/2018 - 12/12/2018 (PDF)
MAC Communication/Notice(s):
12/10/2015 IEHP Maximum Allowable Charges (MAC) Policy Effective 1/1/2016 (PDF)
11/19/2014 IEHP MAC Policy Change (PDF)
01/02/2014 IEHP Maximum Allowable Charges (MAC) Policy (PDF)
Formulary
The IEHP Formulary is a continually updated list of drug products designed to reflect the most appropriate, high quality and cost-effective drug therapies.
The Inland Empire Health Plan Pharmacy and Therapeutics (P & T) Subcommittee develops and monitors the Formulary. The P & T is composed of the IEHP Chief Medical Officer, Medical Directors, Director of Pharmaceutical Services, physicians from various medical specialties, local community and clinical pharmacists. This panel reviews the medications in all therapeutic categories based on safety, clinical efficacy, and cost-effectiveness and selects the most appropriate drugs in each class.
Formulary development and maintenance is a dynamic process. The IEHP P & T Subcommittee is responsible for developing, managing, updating and administering the Formulary. The Subcommittee also ensures that the IEHP Formulary remains responsive to the needs of our members and providers.
You will need Adobe Acrobat Reader 6.0 or later to view the PDF files. Click here to download a free copy by clicking Adobe Acrobat Reader. By clicking on this link, you will be leaving the IEHP website.
IEHP Medi-Cal Formulary Items:
- Medi-Cal Formulary Book (PDF)
- Code 1 List (PDF)
- Medi-Cal PA Drug Criteria Summary (PDF)
- Grievances
- Medi-Cal Formulary Search Tool
- IEHP Medi-Cal Formulary Maintenance Drug List (PDF)
- IEHP Medi-Cal Floor Stock List (PDF)
- Medi-Cal DHCS Carve-Out Medication List (PDF)
IEHP DualChoice Cal MediConnect (Medicare-Medicaid Plan) Items:
- DualChoice Cal MediConnect Formulary Book (PDF)
- Grievance Coverage Determination and Appeals Process
- DualChoice Cal MediConnect Formulary Search Tool
- IEHP DualChoice Cal MediConnect Formulary Maintenance Drug LIst (PDF)
E-prescribing Tips and Tools:
Pharmacy Forms and Manuals
You will need Adobe Acrobat Reader 6.0 or later to view the PDF files. Click here to download a free copy by clicking Adobe Acrobat Reader. By clicking on this link, you will be leaving the IEHP website.
Prior Authorization/Coverage Determination
- Prescription Drug Prior Authorization (Rx PA) Form - For Medi-Cal Members (PDF)
- Request for Medicare Prescription Drug Coverage Determination - For Medicare DualChoice and Medicare DualChoice Cal MediConnect Plans (PDF)
- Request for Redetermination of Medicare Prescription Drug Denial - English (PDF)
- Request for Redetermination of Medicare Prescription Drug Denial - Spanish (PDF)
Drug Request
- Contraceptive Device Prescription Form (PDF)
- Nebulizer Request Form (PDF)
- Request for Addition or Deletion of a Drug to the Formulary (PDF)
- Supplemental PER Form for Compounded Prescription (PDF)
- Synagis Form (PDF)
DTM/Diabetes Management
- Blood Pressure Monitor Request Form (PDF)
- Diabetic Prescription Referral Form - Preveon Health (PDF)
Medicare
- Hospice Form for Medicare Part D Plans (PDF)
- Medicare Prescription Drug Coverage and Your Rights - English (PDF)
- Medicare Prescription Drug Coverage and Your Rights - Spanish (PDF)
Mail Order
Other Pharmacy Provider forms
- Appointment of Representative - English (PDF)
- Appointment of Representative - Spanish (PDF
- Nutritional Evaluation Form - Adult (PDF)
- Nutritional Evaluation Form - Infant (PDF)
- Pain Assessment and Treatment Plan Form (PDF)
- PHQ-9 Modified for Teens (PDF)
- Request for Addition or Deletion of a Drug to the Formulary (PDF)
WIC Program forms (California Department of Public Health)
- Pediatric Referral Form (PDF)
- WIC Referral For Pregnant Women (PDF)
- WIC Referral For Postpartum/Breastfeeding Women (PDF)
Pharmacy Manuals
Pharmacy Network Lists
You will need Adobe Acrobat Reader 6.0 or later to view the PDF files. Click here to download a free copy by clicking Adobe Acrobat Reader. By clicking on this link, you will be leaving the IEHP website.
IEHP Pharmacy Network
- IEHP Pharmacy Network (PDF)
Vaccine Pharmacy Network List
For any questions regarding Pharmacy P4P payments or reports please contact: PharmacyP4P@iehp.org
Use the menu below to view the preferred section:
- Program Overview
- Program Eligibility Criteria
- Program Timeline
- Program Components
- Pharmacy Recognition
- Pharmacy P4P Communication(s)
The IEHP Pharmacy Pay-For-Performance (P4P) Program is set up to improve pharmacy services through the IEHP community pharmacy providers. This is considered one of the first large-scale Pharmacy P4P programs in United States. Our goal is to help validate the roles of community pharmacies in promoting healthcare quality and define a pharmacy payment model for outcome-based MTM services.
The Pharmacy P4P program is steered by a workgroup, comprised of community pharmacists, chains representatives, the Senior Director of IEHP Pharmaceutical Services, and the IEHP Chief Medical Officer.
For more information about previous IEHP Pharmacy P4P Program details, please click here for 2018 or click here for 2013-2017.
Program Eligibility Criteria
In order to participate, pharmacies and pharmacists:
- Must be a contracted IEHP Community Pharmacy Provider
- Must be free of outstanding fraud, waste and abuse investigations
- Must be located within San Bernardino and Riverside Counties
- Must have an annual IEHP prescription volume of over 1,000 (500 in 6 months)
- Shall be remain in business during the entire evaluation period
- Should be credentialed by IEHP
If you are not a current provider, but would like to participate, please contact: PharmacyP4P@iehp.org
P4P Program Timeline
|
Phase |
Timeline |
|
Phase I: Pharmacy P4P Launch |
October 2013 |
|
Phase II: Pharmacy Home Program |
July 4, 2016 - December 31, 2017 |
|
Phase III: Drug Utilization Review |
January 2018 - December 2018 |
|
High Quality Pharmacy Network |
January 2019 – December 2019 |
|
Bi-Annual Evaluation |
Ongoing |
____ Current stage
Program Components
For 2019, the Pharmacy P4P Program will have three main components:
- Drug Utilization Review (DUR): Therapeutic Duplication and High Dose
- Medication Management Measures
- Customer Satisfaction Survey
Drug Utilization Review (DUR)
Drug Utilization Review (DUR) alerts provide patient safety information to pharmacists at point-of-sale (POS). These alerts include a range of safety-related issues to caution pharmacists that the medication may not be appropriate for the member. Pharmacists who actively review DUR alerts and intervene can mitigate the risk of adverse or medication-related events.
DUR alerts and interventions based on High Dose Exceeding First DataBank (FDB) Maximum Recommended Dose and Therapeutic and Ingredient Duplication.
Pharmacists are required to review all relevant DUR alerts, determine the most appropriate intervention, and if necessary, enter one RFS code, one PSC code, and one RSC code in order to allow the prescription to process. For technical support, please refer to your pharmacy point-of-sale system help desk.
Please see the training video and DUR Alerts Pocket Guide below for more information.
DUR Toolkit for Pharmacists:
- Handout to Explain Pharmacy P4P to a Prescriber (pdf)
- How-to-Process at Point-of-Sale for Pharmacists (Training Video) (mp4)
- DUR Alerts Pocket Guide for Pharmacists (pdf)
Chronic Disease Medication Management
The following Chronic Disease Medication Management Clinical Measures are endorsed by the National Committee for Quality Assurance (NCQA) and Pharmacy Quality Alliance (PQA). If you want to learn more about NCQA and PQA, please visit their websites at www.NCQA.org and www.pqaalliance.org.
|
Measurements |
Description |
Performance Threshold |
Performance Improvement |
|
Medication Therapy for Persons with Asthma- Absence of Controller Therapy |
The percentage of patients with asthma during the measurement period who were dispensed more than 3 canisters of short acting beta2 agonist inhalers over a 90-day period and who did not receive controller therapy during the same 90-day period. |
30% |
5% |
|
Medication Therapy for Persons with Asthma-Suboptimal Control |
The percentage of patients with persistent asthma who were dispensed more than 3 canisters of a short-acting beta 2 agonist inhaler during the same 90-day period. |
8% |
2% |
|
Medication Adherence for Cholesterol Medications |
The percentage of patients 18 years and older who met the Proportion of Days Covered (PDC) during the measurement period for medications dispensed in therapeutic classes associated with the disease state. |
85% |
7% |
|
Medication Adherence for Diabetes Medications |
The percentage of patients 18 years and older who met the Proportion of Days Covered (PDC) during the measurement period for medications dispensed in therapeutic classes associated with the disease state. |
85% |
7% |
|
High-Risk Medications |
The percentage of patients 65 years and older who were dispensed a medication classified as high-risk. |
0% |
n/a |
|
Medication Adherence for Hypertension |
The percentage of patients 18 years and older who met the Proportion of Days Covered (PDC) during the measurement period for medications dispensed in therapeutic classes associated with the disease state. |
85% |
7% |
|
Statin Use in Persons with Diabetes |
The percentage of patients ages 40-75 years who were dispensed a medication for diabetes that receive a statin medication. |
75% |
5% |
Performance Expectations:
- Performance improvement: for a specific measure, the pharmacy has met or exceeded the performance improvement percentage (%) for the assigned membership
- Performance thresholds: for a specific measure, the pharmacy has met or exceeded the performance threshold for the assigned membership
For each Clinical Measure, pharmacies will meet payment expectation for that measure if EITHER the Performance improvement OR Performance threshold is met.
- Tier 1: pharmacies meeting five (5) or more measures (for performance improvement or threshold for each measure)
- Tier 2: pharmacies meeting four (4) measures (for performance improvement or threshold for each measure)
- Tier 3: pharmacies meeting three (3) measures (for performance improvement or threshold for each measure)
Helpful Resources for Chronic Disease Management:
- IEHP provides FREE Asthma classes at our Community Resource Center. To enroll, simply call the number listed on the flyer Pharmacy Family Asthma Workshop: English (pdf) | Spanish (pdf)
Member Satisfaction
IEHP rewards pharmacies that engage members and create a member-centered experience. IEHP members are selected at random and surveys are conducted by a third-party vendor.
Recognition will be awarded to high performing pharmacies. These pharmacies will be allowed to promote their achievement to the community.
Pharmacy P4P Communication/Notice(s)
For any questions regarding Pharmacy P4P payments or reports please contact: PharmacyP4P@iehp.org
Pharmacy Quality Star Ratings
What is Pharmacy Quality Rating?
IEHP Pharmacy Quality Rating is created to help IEHP Members to find high-quality local pharmacies for your pharmacy services. This searchable system will display the rating of each participating pharmacy. The ratings range from 1 to 5 stars, with 5 stars being the best and 1 the lowest.
I thought all pharmacies were similar in their services, why do I need to find a pharmacy using this tool?
Usually, the role of a community pharmacy is to fill prescription medications and provide information about them. Some pharmacies offer additional services that may benefit you. The services include, but are not limited to: flu vaccinations, automatic refill reminders, medication reviews, and enhanced consultations. IEHP has been working with our Pharmacies to promote Pharmacy Quality Rating.
Pharmacies that consistently provide IEHP members with quality care and service will earn the highest rating of 5 Stars. These pharmacies will work with your physician to ensure all your important chronic medications are ready for pick up and that you fill them on time. If a pharmacist determines that you were prescribed a medication that is considered not safe for your age, he or she will discuss safer alternatives with you and your doctor. These are just a few examples of how a high quality pharmacy can benefit you.
Do I pick a pharmacy based on how quick they fill my prescriptions, or how close they are from my work or home?
You should select a pharmacy that helps you manage your health conditions. You may select a high-quality pharmacy near your home or work, and then compare their actual service level.
How does IEHP determine the rating?
Pharmacy Quality Rating for Members is still a new concept being developed. Currently, IEHP determines the quality rating based on a set of national guidelines. The guideline suggests that a high quality pharmacy should promote drug adherence (to remind you to take medications on a regular basis), promote the use of the right medication for certain conditions, and reduce the use of unsafe medications. In the future, IEHP will include other measures or services that are being offered by the pharmacy, complaints regarding the pharmacy, etc.
What does the rating scale mean?
The rating is on a scale of 1-5, with 1 being the lowest and 5 being the highest. Please note that some pharmacies may not have any Star Ratings, and that means we don’t have enough information to rate the pharmacy, or the pharmacy is not included in our rating system.
| Star Ratings |
Performance Description |
|---|---|
| 1 Star |
Overall pharmacy performance is well below average |
| 2 Stars |
Overall pharmacy performance is below average |
| 3 Stars |
Overall pharmacy performance is average |
| 4 Stars |
Overall pharmacy performance is good |
| 5 Stars |
Overall pharmacy performance is exceptional |
| No Star |
No information is available for this pharmacy |
Latest Update (as of 6/01/18):
Provider Communications
IEHP Pharmaceutical Services serves a variety of provider communications notices from most recent P&T Formulary changes to current PER processing changes, and even CME event invitations. The published notifications are grouped respectively for: